Skip to main content

Table 1 Demographic data, medication (levodopa equivalent) and clinical scores.

From: Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms

 

CTL

PD-DA

PD-DBS

   

on

off

Number of subjects

total (male, female)

23 (18m, 5f)

34 (21m, 13f)

14 ( 9m, 5f)

Age (yrs)

mean (± SD), range

61.7 (± 7.1), 49-76

63.0 (± 11.7), 36-81

64.2 (± 7.1), 50-74

Disease duration (yrs)

mean (± SD), range

 

6.9 (± 4.4), 1-16

10.5 (± 4.0), 4-19

Levodopa equivalent medication (mg/day)

mean (± SD), range

 

917 (± 578), 200-2650

509 (± 348), 0-1250

UPDRS motor scale

mean (± SD), range

 

20.3 (± 13.0), 2-56

29, 0 (± 16.3), 5-62

38.8 (± 14.3), 16-64

  1. Equivalent doses are given according to Tomlinson et al., 2010 [15]